BRY — Bri-Chem Income Statement
0.000.00%
- CA$7.67m
- CA$32.10m
- CA$83.07m
- 40
- 95
- 38
- 59
Annual income statement for Bri-Chem, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 45.2 | 60.4 | 105 | 106 | 83.1 |
Cost of Revenue | |||||
Gross Profit | 7.33 | 12.2 | 21.1 | 18.7 | 14.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 50.1 | 59.3 | 99.2 | 105 | 87.3 |
Operating Profit | -4.92 | 1.15 | 5.27 | 0.85 | -4.19 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -5.12 | 1.29 | 4.62 | 1.41 | -4.97 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.15 | 1.32 | 8.64 | 0.909 | -3.85 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.15 | 1.32 | 8.64 | 0.909 | -3.85 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.15 | 1.32 | 8.64 | 0.909 | -3.85 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.212 | 0.048 | 0.327 | 0.034 | -0.145 |